Objective. Chronic obstructive pulmonary disease (COPD) is a major and difficult disease of
the chronic respiratory system that is common and frequent, with a huge disease burden …

Background For patients with chronic obstructive pulmonary disease (COPD), greater
improvements in lung function have been demonstrated for triple versus dual inhaled …

Background Triple therapy with inhaled corticosteroids/long-acting muscarinic
antagonists/long-acting β 2-agonists (ICS/LAMA/LABA) is recommended for patients with …

Budesonide/glycopyrronium/formoterol (BREZTRI AEROSPHERE™; TRIXEO
AEROSPHERE™) is an inhaled fixed-dose combination of the inhaled corticosteroid (ICS) …

PURPOSE: Functional respiratory imaging (FRI) has previously demonstrated the efficacy of
dual bronchodilator therapies in chronic obstructive pulmonary disease (COPD) via …

PURPOSE: Gamma scintigraphy allows assessment of the total lung deposition, regional
distribution, and extrathoracic (oropharyngeal and stomach) deposition of inhaled treatment …

Introduction This pre-specified subgroup analysis evaluated the efficacy and safety of
budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) triple …

Background: In the phase III, 52-week ETHOS study in patients with moderate to very severe
chronic obstructive pulmonary disease (COPD), triple therapy with budesonide …

The GOLD classification of COPD does not always matches with other clinical disease
descriptors such as exacerbation frequency and quality of life indicating that FEV1 is not a …

Background We report the long-term effects of triple therapy with budesonide/glycopyrrolate/
formoterol fumarate (BGF) vs glycopyrrolate/formoterol fumarate (GFF) and …